John A Allen

Title: Innovations of John A. Allen

Introduction

John A. Allen is a notable inventor based in Galveston, Texas. He has made significant contributions to the field of pharmacology, particularly in the development of G-protein-coupled receptor agonists. With a total of two patents to his name, Allen's work has the potential to impact various human diseases.

Latest Patents

Allen's latest patents focus on Heterocyclic G-protein-coupled receptor 52 (GPR52) agonists. These embodiments are directed to novel GPR52 activators, specifically a series of novel 1-(pyrimidin-4-yl)indoline-4-carboxamide analogs. These compounds have been identified as potent and selective GPR52 agonists. The optimized GPR52 agonist can serve as a valuable pharmacological tool or a drug candidate for investigating the physiological and therapeutic potential of GPR52 activation for various human diseases.

Career Highlights

Throughout his career, John A. Allen has worked with esteemed institutions such as the University of Texas System and the Board of Regents of the University of Texas System. His work in these organizations has allowed him to further his research and contribute to advancements in medical science.

Collaborations

Some of Allen's notable coworkers include Jia Zhou and Pingyuan Wang. Their collaborative efforts have likely enhanced the research and development of GPR52 agonists.

Conclusion

John A. Allen's innovative work in the field of pharmacology, particularly with GPR52 agonists, showcases his dedication to advancing medical science. His contributions have the potential to lead to significant therapeutic advancements for various human diseases.